[11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

Synapse

Volumn 39, Issue 4, 2001, Pages 332-342

  Fischman, Alan J ^a   Bonab, Ali A ^a   Babich, John W ^b   Livni, E ^c   Alpert, Nathaniel M ^b   Meltzer, Peter C ^a   Madras, Bertha K ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ORGANIX INC   (United States)

Author keywords

Cocaine; Dopamine neurons; Movement disorders; Parkinson disease; SPECT imaging; WIN 35,428

Indexed keywords

ALTROPANE; CARBON 11; DOPAMINE TRANSPORTER; DRUG METABOLITE; ESTER; IODINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IODINE RADIOISOTOPES; KINETICS; LIGANDS; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035869767     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20010315)39:4<332::AID-SYN1017>3.0.CO;2-X     Document Type: Article

References (61)

1. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT
2. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease
3. 123I]N-ω-fluoroalkyl-2β-carboxy-3β-(4-iodophenyl) nortropane esters in baboons
4. 123I] beta-CIT in human plasma may obstruct quantitation of the dopamine transporter
5. 125I]RTI-55: A potent ligand for dopamine transporters
6. 123I] Altropane
7. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease
8. 123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease
9. 3H]WIN 35,428) in the monkey brain
10. 18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta (4′ methylphenyl) nortropane (FPCMT)
11. 3H]imipramine
12. Dopamine transporter density in patients with attention deficit hyperactivity disorder
13. 123I]beta-CIT) in untreated patients with suspicion of Parkinson disease
14. Preparation and biological evaluation of iodine-125-IACFT: A selective SPECT agent for imaging dopamine transporter sites
15. 11C]β-CIT binding to monoamine transporters in the monkey and human brain
16. 123I] IACFT): Initial experience in humans
17. SPECT imaging of dopamine transporter sites in normal and MPTP treated rhesus monkeys
18. Rapid detection of Parkinson's disease by SPECT with Altropane: A selective ligand for dopamine transporters
19. 11C -WIN 35,428 reveals marked declines in mild Parkinson's disease
20. 11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: Implications for the symptomatic threshold
21. 123C]β-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography
22. 11C-CFT and PET in a primate model of parkinsonism
23. 123I]CIT
24. Comparative nigrostriatal dopaminergic imaging with iodine-123-β CIT-FP/SPECT and fluorine-18-FDOPA/PET
25. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum
26. 125I]RTI-55
27. 3H]WIN 35,428) accumulation in dopamine regions of monkey brain: Comparison of a mature and an aged monkey
28. Dopamine transporter imaging with fluorine-18-FPCIT and PET
29. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
30. Iodine-123 labelled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain
31. Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl) tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain
32. 123I]beta-CIT: Pharmacological characterization of brain uptake in nonhuman primates
33. 123I] beta-CIT binding to dopamine transporters in healthy human subjects
34. Unilateral MPTP lesion in a rhesus monkey: Effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers
35. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease
36. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers
37. 11C]β-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: Preparation, autoradiography, metabolite studies, and positron emission tomography examinations
38. Cocaine accumulates in dopaminerich regions of primate brain after i.v. administration: Comparison with mazindol distribution
39. 3H]2β-carbomethoxy-3β-(4-fluorophenyl) tropane
40. Cocaine receptor probes in human and nonhuman primate brain: In vivo characterization and in vivo imaging
41. Altropane, a SPECT or PET imaging probe for dopamine neurons. I. Dopamine transporter binding in primate brain
42. Altropane, a SPECT or PET imaging probe for dopamine neurons. II. Distribution to dopamine-rich regions of primate brain
43. Altropane, a SPECT or PET imaging probe for dopamine neurons. III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain
44. 123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
45. Altered dopamine transporter densities in alcohol-preferring vervet monkeys
46. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
47. 18F]dopa PET
48. 11C] [β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations
49. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in brain
50. N-ω-fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl)-tropane (β-CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters
51. Cocaine receptors on dopamine transporters are related to self-administration of cocaine
52. 11C] nomifensine uptake using positron emission tomography
53. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects
54. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease
55. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55
56. 123I]beta-CIT SPECT
57. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT
58. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
59. Relationship between subjective effects of cocaine and dopamine transporter occupancy
60. 11C-WIN 35,428
61. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo